Market Definition: Global Neurostimulation Market
Neurostimulation is the process which provides mild electrical pulses to your spine, causing a tingling sensation in the area of your chronic pain. It is used for the treatment of various unbearable conditions such as gastroparesis, incontinence, Parkinson’s disease, epilepsy, depression and essential tremors. Neurostimulation is a highly probable treatment option for patients who do not attain relief from medications and surgical therapies. Increased in the chronic diseases such as migraine and epilepsy boosts the market growth.
Major market drivers and restraints: Global Neurostimulation Market
- Increasing global prevalence of chronic diseases
- Introduction of technological advancements
- Growing geriatric population
- Growing demand for minimally invasive surgeries
- Growing demand for neurostimulation devices
Market Segmentation: Global Neurostimulation Market
The global neurostimulation market is segmented by device type into implantable device and external device. Implantable device are sub segmented into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators and gastric electric stimulators. External device are sub segmented into transcutaneous electrical nerve stimulation and transcranial magnetic stimulation.
By Application the market is segmented into pain management, epilepsy, essential tremor, urinary & fecal incontinence, depression, dystonia, gastroparesis and Parkinson's disease.
On the basis of geography, neurostimulation market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Competitive Analysis: Global Neurostimulation Market
The neurostimulation market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of neurostimulation market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors: Global Neurostimulation Market
Some of the major players operating in neurostimulation market are Medtronic, Abbott, Boston Scientific Corporation, LivaNova PLC, Cochlear Ltd., MED-EL, Nevro Corp., Neuronetics, Cogentix Medical, Johnson & Johnson Services Inc., NeuroPace, Inc., NeuroSigma, Inc., NDI, IntraPace, Inc., BioControl Medical, Synapse Biomedical Inc., Biegler GmbH, Stimwave LLC, Modulus, Inc. and Integer Holdings Corporation among others.
Research Methodology: Global Neurostimulation Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or drop down your inquiry.
Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.